Supplying Medicines and Supplements to Bangladesh
A practical guide for Bangladeshi importers, hospitals and distributors who source from abroad, and for manufacturers and exporters worldwide selling into Bangladesh.
Bangladesh's own industry meets about 98% of its demand for medicines, so imports fill the gaps: biologicals, oncology and other specialised products. For those products the market is real and growing.
One date matters for everyone. Bangladesh is scheduled to graduate from Least Developed Country status on 24 November 2026, which ends its waiver on pharmaceutical patents. It has asked for a three-year deferral, and the UN is considering the request in October 2026.
Bangladesh at a glance
| Regulator | Directorate General of Drug Administration (DGDA), under the Drugs and Cosmetics Act 2023 |
|---|---|
| Who applies | A local nominated representative applies for the foreign manufacturer |
| Registration | A CoPP or free sale certificate, with the product generally registered in one of seven reference countries: Australia, France, Germany, Japan, Switzerland, the UK or the USA. Renewed every five years |
| Import quantities | DGDA approves the quantity for each import, often less than requested |
| Pricing | The government sets prices for essential medicines; the list was expanded to about 295 products in January 2026 |
How to supply medicines to Bangladesh
- Appoint a local representative. A local nominated representative applies to DGDA for the foreign manufacturer and handles imports.
- Prepare the dossier. A CTD dossier with a CoPP or free sale certificate and the plant's GMP evidence. DGDA can inspect foreign sites, and pack samples are submitted in English or Bengali.
- Allow time for the decision. DGDA's Drug Control Committee decides. A large backlog built up in 2024–25, so plan for delays.
- Supply. Private importers and hospitals for specialised products. The state manufacturer, EDCL, supplies most medicines to public facilities.
Unregistered medicines can be imported only in set quantities, for a named patient or for research, with DGDA's prior approval. See named-patient and special import and government tender supply.
Supplements
Since August 2025, health and dietary supplements have been regulated by the Bangladesh Food Safety Authority (BFSA), and importers must register each product with it. Food labels need Bengali text or a Bengali sticker. We help brands get supplements made under their own label by GMP-certified contract manufacturers: see nutraceutical private label.
What people in Bangladesh search for
Semrush data from October 2026 shows that people in Bangladesh search most for vitamins: vitamin D (about 14,800 searches a month), B12, B complex and vitamin C. Protein, collagen, omega-3, ashwagandha and magnesium glycinate follow.
Supplements we can help you make
Because local plants make most generics, imports are mainly specialised and hospital products. Some examples we list:
Documents to ask your supplier for
- A Certificate of a Pharmaceutical Product (CoPP) in WHO format.
- The plant's GMP evidence, such as a WHO-GMP, EU-GMP or PIC/S certificate, plus any inspection by your regulator.
- The registration dossier (CTD or ACTD), with bioequivalence data for generics where required.
- Stability data for hot climates.
- A Certificate of Analysis for every batch.
Not sure a supplier is genuine? Read how to verify a pharmaceutical supplier. For the neighbouring markets, see our South Asia and SAARC import guide.
Sourcing for Bangladesh?
Send the product, strength, quantity and the documents your regulator needs. We will match you with GMP-certified manufacturers and suppliers who can serve your market, wherever they are based.
Send your requirement Talk to our team